GlycoGenetics, Inc. is a glycobiology-centric biotechnology company. We use genetics-enabled technologies to develop molecular tools to decipher complex human glycocodes and to expedite clinical applications of glycobiology. Our core business comprises three main aspects:  

• Recombinant human lectins as molecular glycocode readers;

• Glyco-screening platforms for biomarker and  drug discovery; 

• Glycocode reader-based in vitro diagnostics for unmet medical needs.